Estudio epidemiologico, clinico e inmunologico de pacientes coinfectados con HIV y HTLV-1

Scapellato, Pablo G; Bottaro, Edgardo G; Seoane, Maria B; Brieschke, Maria T. Rodriguez; Scapellato, Jose L; Dato, Adriana; Vidal, Gabriela I.
Medicina (B.Aires) ; 64(5): 413-418, 2004. tab
Artigo em Espanhol | LILACS | ID: lil-392306

Documentos relacionados

  1. Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis.
  2. Why not eliminate HTLV-1 while eliminating HIV-1?
  3. Human T-lymphotropic virus type 1 infection and solid organ transplantation.
  4. Pulmonary Disease Is Associated With Human T-Cell Leukemia Virus Type 1c Infection: A Cross-sectional Survey in Remote Aboriginal Communities.
  5. The slowdown of new infections by human retroviruses has reached a plateau in Spain.
  6. Seronegative human T-cell lymphotropic virus 1 carriers in blood banks: A potential viral source for silent transmission?
  7. Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?
  8. Human T Cell Lymphotropic Virus Type 1 Global Prevalence Associated with the Human Development Index: Systematic Review with Meta-Analysis.
  9. Estimation of human T-lymphotropic virus incidence in blood donors from observed prevalence.
  10. Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.